Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jossa

Showing results (51-60 of 53) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 53 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 4, 2018
Expression of MT4-MMP, EGFR, and RB in Triple-Negative Breast Cancer Strongly Sensitizes Tumors to Erlotinib and Palbociclib Combination TherapyPierre Foidart, Cassandre Yip, Jean Radermacher, et al.
Scientific Reports|December 14, 2017
Transcriptome-wide analysis of natural antisense transcripts shows their potential role in breast cancerStephane Wenric, Sonia ElGuendi, Jean-Hubert Caberg, et al.
Plos One|August 31, 2013
Genomic Grade Index (GGI): feasibility in routine practice and impact on treatment decisions in early breast cancerOtto Metzger-Filho, Aurélie Catteau, Stefan Michiels, et al.
Pageof 6

Showing results (51-60 of 53) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 53 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 4, 2018
Expression of MT4-MMP, EGFR, and RB in Triple-Negative Breast Cancer Strongly Sensitizes Tumors to Erlotinib and Palbociclib Combination TherapyPierre Foidart, Cassandre Yip, Jean Radermacher, et al.
Scientific Reports|December 14, 2017
Transcriptome-wide analysis of natural antisense transcripts shows their potential role in breast cancerStephane Wenric, Sonia ElGuendi, Jean-Hubert Caberg, et al.
Plos One|August 31, 2013
Genomic Grade Index (GGI): feasibility in routine practice and impact on treatment decisions in early breast cancerOtto Metzger-Filho, Aurélie Catteau, Stefan Michiels, et al.
Pageof 6